Home > Healthcare & Medical Devices > Sleep Apnea Devices Market

Sleep Apnea Devices Market Size By Product (Therapeutics {Airway Clearance System, Adaptive Servo-ventilation {ASV}, Positive Airway Pressure {PAP} Device, Oral Appliances, Oxygen Devices}, Diagnostics {Actigraphy Systems, Polysomnography {PSG} Device, Respiratory Polygraph, Sleep Screening Devices}), By End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI489
  • Published Date: Mar 2022
  • Report Format: PDF

Industry Overview

Sleep Apnea Devices Market size exceeded USD 6.9 billion in 2021 and is estimated to register over 8.1% CAGR between 2022 and 2028. Surging prevalence of sleep apnea and related co-morbidities along with growing awareness regarding sleep disorders is amongst the major factors stimulating the overall market growth.
 

Sleep Apnea Devices Market

Get more details on this report - Request Free Sample PDF
 

Technological advancement is set to propel sleep apnea devices market growth during the forecast period. These advancements in oral appliances, oxygen devices, actigraphy systems have increased the sleep disorders treatment outcome and success rate. Industry players are focusing on research and development activities for developing innovative technologies. For instance, ResMed launched AirMini, the smallest PAP device that is connected to the remote patient monitoring platform of AirView. This device enable patients to see their data on their phones. Hence, the commercialization of such advanced devices will accelerate the market growth over the coming years.
 

Similarly, the recently introduced lightweight portable sleep apnea products are combined with pressure compensating sensors that can compensate altitude-related drops in atmospheric pressure, thereby increasing its adoption. Such devices are gaining popularity as it is delivering more choice and flexibility for patients. Thus, the use of technology-enabled sleep apnea devices for both diagnostic and treatment purposes in different sleep disorders is anticipated to upsurge significantly in the forthcoming years.
 

Sleep apnea devices are employed for managing and facilitating breathing in patients suffering from sleep disorders. Sleep apnea devices incorporate steady oxygen flow and assist the airway management, thereby facilitating normal breathing.
 

However, lack of adherence to sleep apnea treatment is amongst the major factors hampering the adoption of sleep apnea devices. Positive airway pressure sleep apnea devices are highly recommended for the treatment of different sleep disorders. Despite the high effectiveness of these devices, action efficacy is restricted in several cases attributable to it requiring accurate & regular usage and constant medical supervision. As per the National Center for Biotechnology Information published studies, around 29% - 83% of patients are not adherent with continuous positive airway pressure ventilation.
 

In the short run, this lack of adherence will be a major factor restricting sleep apnea devices market growth. However, in the long run, it will not have a very significant impact as the manufacturers emphasize making their products technologically advanced and reducing the drawbacks related to their adherence to sleep apnea treatment.
 

The COVID-19 arose as an unprecedented public health concern that has affected over millions of individuals worldwide causing significant mortalities. The lockdowns were imposed in the majority of the countries to curb the further transmission of SARS-CoV-2. Hospital admissions and facilities were delivered to the COVID patients on a priority basis, with the majority of the other medical procedures on halt.
 

In the initial 2020, the incidence, as well as the mortality rate due to coronavirus was highest and people preferred to avoid any other treatment procedures at such facilities. Scheduled appointments and the majority of other disease conditions comprising sleep disorders were referred to as non-emergent. Thus, the unprecedented effect of COVID-19 has affected the use of sleep apnea devices in 2020 however, the market gradually risen from second half of 2021 and is expected to grow considerably in the coming years.  
 

However, the use of sleep apnea devices, especially in home care settings was increased during the pandemic period. Heavy patient inflow and rising pressure on healthcare facilities surged the adoption of these devices in home care settings in order to treat sleep disorders efficiently without visiting hospitals. The favourable initiatives employed during COVID-19 have also contributed to the significant product demand. For instance, the American Academy of Sleep Medicine published guidelines associated with the sleep diseases management of individuals infected with coronavirus infection.
 

Further, in response to COVID-19, treatment of such diseases is being restructured to ensure that patients receive an easy access to sleep facilities and other health care providers with required resources. Thus, the market growth was hampered in the initial phase of 2020; however, the surged demand for home care and favourable initiatives are anticipated to uplift the sleep apnea devices market sales in the coming years positively.
 

Growing prevalence of sleep apnea and related co-morbidities is expected to fuel the market statistics

The rising prevalence of sleep disorders and related co-morbidities are expected to boost the market revenue significantly. The rapidly growing geriatric population suffering from sleep apnea and associated health conditions have accelerated the demand for sleep disorders diagnosis & treatment that has further propelled the sleep apnea devices market revenue positively.
 

Sleep disorders comprising obstructive sleep apnea is the most common sleep-related breathing disorder that promotes substantial disease burden. These conditions inflict health care costs and affect the health-associated quality of life. As per the American Sleep Apnea Association (ASAA) data published in 2019, around 22 million people were suffering from sleep apnea in the U.S.
 

According to the Asian Pacific Society of Respirology Journal 2020, one-seventh of the global adult population, or around 1 billion people, are estimated to have obstructive sleep apnea (OSA). Hence, owing to the above statistics, the rising prevalence of sleep apnea and related co-morbidities is set to increase the demand for sleep apnea devices that will prove beneficial for sleep apnea devices market expansion.

 

Advent of novel therapeutic sleep apnea devices is projected to propel the overall market size

Global Sleep Apnea Devices Market Share, By Product

Get more details on this report - Request Free Sample PDF
 

Based on product, sleep apnea devices market is segmented as therapeutics and diagnostics. The therapeutics segment held a dominant market share in the global sleep apnea devices market and was valued at USD 4,311 million in 2021. The surging prevalence of sleep disorders along with increasing demand for novel therapeutics in sleep apnea management is anticipated to drive the adoption of therapeutic sleep apnea devices.
 

Moreover, substantial research and development activities by key industry players are expected to provide novel therapeutic devices that would further benefit the market. Such technological advancements are lessening the disadvantages associated with conventional devices.
 

This further makes them more convenient, efficient, and easy to use with minimum side effects. For instance, Fisher & Paykel Healthcare launched F&P Evora, a novel nasal mask intended for obstructive sleep apnea (OSA) therapeutics. Additionally, the integration of computer-assisted development and manufacturing will offer more innovations in devices that enable more freedom of movement during sleep.
 

Increasing utilization of sleep apnea devices at home care settings is anticipated to drive the industry landscape

Global Sleep Apnea Devices Market Share, By End-use

Get more details on this report - Request Free Sample PDF
 

Based on end-use, sleep apnea devices market is segmented as home care settings & individuals and sleep laboratories & hospitals. The home care settings & individuals segment was valued at USD 3,890 million in 2021 and is expected to witness significant growth during the estimation timeframe owing to the surging adoption & launch of user-friendly homecare sleep apnea devices, rising awareness related to home healthcare, etc. As per the research studies published in 2018, around 1/3rd of sleep apnea testing was carried out at the home care settings.
 

The prominent industry players are also emphasized developing novel sleep apnea devices for their optimum utilization at home care settings. For instance, Itamar Medical announced the U.S. FDA approval for its WatchPAT One, an entirely one-use home sleep apnea test. These tests deliver optimum accuracy and reliability for patients in home care settings. Such product developments are expected to drive the use of sleep apnea devices in home care settings.
 

Suring incidence of sleep apnea and related co-morbidities in North America is expected to stimulate the regional business landscape

Global Sleep Apnea Devices Market Share, By Region

Get more details on this report - Request Free Sample PDF
 

U.S. sleep apnea devices market is anticipated to surpass USD 4,269 million by 2028. This dominant market share is attributable to several factors such as the presence of major industry players, an increase in the number of individuals suffering from sleep apnea and related co-morbidities, etc. As per the Sleep Foundation 2021 data, snoring was estimated to affect 57% of men and 40% of women in the U.S.
 

Further, as per the Sleep Advisor Organization article 2021, more than 4,700 sleep labs are currently operating in the U.S. Thus, the diagnosis and treatment of sleep disorders have been significantly rising in the U.S. over the past few years. Moreover, the presence of key sleep apnea devices industry players such as Koninklijke Philips N.V., Fisher & Paykel Healthcare, and Nihon Kohden among others in the country are engaged in new product development & commercialization that facilitates industrial expansion in the U.S.
 

Business growth strategies implemented by major market players will amplify the industry expansion

Some of the major players operating in the sleep apnea devices market are Koninklijke Philips N.V., Fisher & Paykel Healthcare, ResMed Inc., Invacare Corporation, Natus Medical Inc., and Teleflex Inc., among others. Several strategic initiatives such as novel product launches, mergers, acquisitions, strategic collaborations, and geographic expansion to gain competitive advantages are being undertaken. These prominent market players also emphasize on research and development activities that allows in garnering maximum revenue.
 

Recent industry developments:

  • In January 2021, Itamar Medical acquired technology and assets of Spry Health. This acquisition helped Itamar to leverage Spry’s existing technology to bring the device for continuous remote patient monitoring (RPM) of sleep apnea. This strategic move helped the company gain market expansion opportunity in the growing sleep apnea devices market.
     
  • In August 2020, Nihon Kohden launched polysmith 12 software for their polysomnography devices. This software is a version 12 of the polysmith software that includes more than 40 market-driven features that offer sleep specialists improved workflow, analysis, and outcomes for the patients. This product launch enabled the company to broaden its product portfolio, thereby driving the market share.
     

Sleep apnea devices market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

By Product

  • Therapeutics
    • Airway Clearance Systems
    • Adaptive Servo-ventilation (ASV)
    • Positive Airway Pressure (PAP) Device
    • Oral Appliances
    • Oxygen Devices
    • Others
  • Diagnostics
    • Actigraphy Systems
    • Polysomnography (PSG) Device
    • Respiratory Polygraph
    • Sleep Screening Devices

By End-use

  • Home Care Settings & Individuals
  • Sleep Laboratories & Hospitals

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
       
Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

In 2021, sleep apnea devices industry revenue was about USD 6.9 billion and is anticipated to surpass USD 12.5 billion over 2022-2028 driven by rising awareness about sleep disorders.

The overall market share from the therapeutics segment was recorded at USD 4,311 million in 2021 and could grow with the increase in research and development activities related to novel therapeutic devices by major market players.

The industry size from home care settings & individuals was recorded at USD 3,890 million in 2021 and could grow with growing awareness about home healthcare and the advent of user-friendly homecare sleep apnea devices.

North American market for sleep apnea devices led by the U.S. could reach nearly USD 4,269 million between 2022 and 2028 owing to the rising prevalence of sleep apnea and related co-morbidities.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 13
  • Tables & Figures: 244
  • Countries covered: 18
  • Pages: 100

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount